Xiaolan Tian

588 total citations
23 papers, 375 citations indexed

About

Xiaolan Tian is a scholar working on Epidemiology, Rheumatology and Immunology. According to data from OpenAlex, Xiaolan Tian has authored 23 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 8 papers in Rheumatology and 5 papers in Immunology. Recurrent topics in Xiaolan Tian's work include Inflammatory Myopathies and Dermatomyositis (20 papers), Eosinophilic Disorders and Syndromes (7 papers) and Muscle Physiology and Disorders (4 papers). Xiaolan Tian is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (20 papers), Eosinophilic Disorders and Syndromes (7 papers) and Muscle Physiology and Disorders (4 papers). Xiaolan Tian collaborates with scholars based in China. Xiaolan Tian's co-authors include Hanbo Yang, Xiaoming Shu, Xin Lü, Guochun Wang, Qinglin Peng, Guochun Wang, Sigong Zhang, Xin Lu, Yinli Zhang and Yinli Zhang and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaolan Tian

19 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolan Tian China 11 237 170 126 68 61 23 375
Levente Bodoki Hungary 8 333 1.4× 225 1.3× 68 0.5× 111 1.6× 43 0.7× 28 428
Boaz Palterer Italy 12 133 0.6× 157 0.9× 111 0.9× 46 0.7× 49 0.8× 33 362
Yosuke Ishitsuka Japan 12 156 0.7× 94 0.6× 129 1.0× 115 1.7× 44 0.7× 34 443
Melinda Nagy‐Vincze Hungary 9 357 1.5× 232 1.4× 59 0.5× 97 1.4× 37 0.6× 26 420
Lenka Pleštilová Czechia 12 227 1.0× 152 0.9× 147 1.2× 181 2.7× 20 0.3× 23 420
Isamu Kingetsu Japan 11 132 0.6× 102 0.6× 93 0.7× 104 1.5× 32 0.5× 24 355
Masaomi Yamasaki Japan 8 396 1.7× 276 1.6× 61 0.5× 91 1.3× 144 2.4× 11 542
Yasuyuki Todoroki Japan 10 96 0.4× 110 0.6× 123 1.0× 75 1.1× 30 0.5× 30 292
Yuzhou Gan China 10 91 0.4× 130 0.8× 105 0.8× 48 0.7× 40 0.7× 25 274
L. Burke United States 8 80 0.3× 111 0.7× 62 0.5× 67 1.0× 117 1.9× 11 374

Countries citing papers authored by Xiaolan Tian

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Tian more than expected).

Fields of papers citing papers by Xiaolan Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Tian. The network helps show where Xiaolan Tian may publish in the future.

Co-authorship network of co-authors of Xiaolan Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolan Tian. A scholar is included among the top collaborators of Xiaolan Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolan Tian. Xiaolan Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Chao, Xiaolan Tian, Shanshan Li, Guochun Wang, & Xin Lu. (2025). Tongue myositis in dermatomyositis with anti-PM-Scl 75 antibody: two case reports. BMC Musculoskeletal Disorders. 26(1). 868–868.
2.
Tian, Xiaolan, Chao Sun, Wei Jiang, et al.. (2025). Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study. PLoS ONE. 20(2). e0317319–e0317319.
3.
Tian, Xiaolan, Hongxia Yang, Hanbo Yang, et al.. (2024). Polymyositis is a rare and favourable outcome subtype of idiopathic inflammatory myopathy in Chinese patients. Clinical and Experimental Rheumatology. 42(2). 302–308.
4.
Yang, Hongxia, Lining Zhang, Xiaolan Tian, et al.. (2024). Distinct phenotype and prognosis of immune-mediated necrotizing myopathy based on clinical–serological–pathological classification. Lara D. Veeken. 64(4). 2252–2264. 2 indexed citations
5.
Tian, Xiaolan, Linrong He, Wei Jiang, et al.. (2024). Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: Prevalence, risk factors, and prognosis. Seminars in Arthritis and Rheumatism. 65. 152352–152352. 2 indexed citations
6.
Sun, Chao, Qinglin Peng, Wei Jiang, et al.. (2024). Validation of the 2018 (New) ENMC Classification Criteria for Dermatomyositis in Chinese Patients with Idiopathic Inflammatory Myopathies. Clinical Rheumatology. 43(12). 3799–3807.
7.
Xia, Qisheng, Wenli Li, Qingyan Liu, et al.. (2023). Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I. RMD Open. 9(1). e002818–e002818. 5 indexed citations
8.
Fu, Lijun, Hongxia Yang, Zhenguo Huang, et al.. (2023). Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti‐MDA5‐positive dermatomyositis. Journal of Internal Medicine. 293(4). 494–507. 34 indexed citations
9.
Zhang, Lining, Hanbo Yang, Hongxia Yang, et al.. (2022). Serum levels of anti-transcriptional intermediary factor 1-γ autoantibody associated with the clinical, pathological characteristics and outcomes of patients with dermatomyositis. Seminars in Arthritis and Rheumatism. 55. 152011–152011. 6 indexed citations
10.
Yang, Hongxia, Xiaolan Tian, Lining Zhang, et al.. (2022). Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort. BMC Musculoskeletal Disorders. 23(1). 425–425. 10 indexed citations
11.
Ge, Yongpeng, Shanshan Li, Xiaolan Tian, et al.. (2021). Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy. Clinical Rheumatology. 40(6). 2311–2317. 33 indexed citations
12.
Zhang, Yinli, Yongpeng Ge, Hanbo Yang, et al.. (2020). Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome. Clinical Rheumatology. 39(8). 2417–2424. 19 indexed citations
13.
Jiang, Wei, et al.. (2020). Clinical features, treatments and outcomes of calcinosis in adult patients with dermatomyositis: a single cohort study. Lara D. Veeken. 60(6). 2958–2962. 10 indexed citations
14.
Zhang, Lining, Hongyan Liu, Xiaolan Tian, et al.. (2019). The role of muscle biopsy score in assessing disease activity in adult patients with idiopathic inflammatory myopathies. 23(2). 76–81. 1 indexed citations
15.
Shu, Xiaoming, Fang Chen, Qinglin Peng, et al.. (2017). Potential role of autophagy in T-cell survival in polymyositis and dermatomyositis. Molecular Medicine Reports. 16(2). 1180–1188. 12 indexed citations
16.
Li, Wenli, Xiaolan Tian, Xin Lü, et al.. (2016). Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis. Scientific Reports. 6(1). 27479–27479. 27 indexed citations
17.
Lü, Xin, Hanbo Yang, Xiaoming Shu, et al.. (2014). Factors Predicting Malignancy in Patients with Polymyositis and Dermatomyostis: A Systematic Review and Meta-Analysis. PLoS ONE. 9(4). e94128–e94128. 88 indexed citations
18.
Peng, Qinglin, Xiaoming Shu, Xiaolan Tian, Xin Lu, & Guochun Wang. (2014). Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis. Arthritis Research & Therapy. 16(1). R26–R26. 11 indexed citations
19.
20.
Tian, Xiaolan, Marisabel Mourelle, Yuling Li, Francisco Guarner, & Juan R. Malagelada. (2000). Role of Chinese herbal medicines in a rat model of chronic colitis. World Journal of Gastroenterology. 6. 66–66. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Levente Bodoki Breakdown of academic impact, for papers by Boaz Palterer Breakdown of academic impact, for papers by Yosuke Ishitsuka Breakdown of academic impact, for papers by Melinda Nagy‐Vincze Breakdown of academic impact, for papers by Lenka Pleštilová Breakdown of academic impact, for papers by Isamu Kingetsu Breakdown of academic impact, for papers by Masaomi Yamasaki Breakdown of academic impact, for papers by Yasuyuki Todoroki Breakdown of academic impact, for papers by Yuzhou Gan Breakdown of academic impact, for papers by L. Burke
Rankless by CCL
2026